Kathy Giusti, M.B.A. ’85, founder and CEO of the Multiple Myeloma Research Foundation (MMRF), will address this year's imminent graduates of Harvard Business School as Class Day speaker. She founded the MMRF in 1998 after being diagnosed with multiple myeloma. This spring, Time magazine named her one of the "100 most influential people" in the world. Multiple myeloma is a cancer of plasma cells—white blood cells that produce antibodies; it affects from one to four people per 100,000 and constitutes 1 percent of all cancers. Before starting MMRF, Giusti was an executive with pharmaceutical companies, and she has sought to encourage the development of drugs to treat the disease using a business model, rather than an academic model, of drug development. The MMRF is the world's top funder of myeloma research: it has raised more than $165 million to fund research.
Kathy Giusti to Address HBS Graduating Class
The founder of the Multiple Myeloma Research Foundation will speak at Harvard Business School Class Day.
You might also like
The School of Public Health, Facing a Financial Reckoning, Seizes the Chance to Reinvent Itself
Dean Andrea Baccarelli plans for a smaller, more impactful Chan School of 2030.
Harvard Adopts Reforms as Higher Ed Turmoil Continues
University creates new “interfaith engagement” role; Columbia, Brown settle with the government.
“Do You Find That Reasonable?” Harvard Undergraduates Discuss a Changing University
A student panel grapples—civilly—with shifting policies and differing opinions.
Most popular
Explore More From Current Issue
Alumni showed increased interest in this year’s elections.
Erica Chenoweth’s data shows how—and when—authoritarians fall.
David Leo Rice explores the strange, unseen forces shaping our world.